OVERVIEW
Vic Market Research Co., Ltd. is pleased to announce the release of the “Global and Chinese Pharmacogenomics Technology (Theranostics & CDx) Market Insight Report 2025–2031.”
This comprehensive study is designed to provide a structured and in-depth analysis of the Pharmacogenomics Technology (Theranostics & CDx) industry, both domestically and internationally, with a focus on the following key areas:
1.An overview and assessment of the current development status and emerging trends in the Pharmacogenomics Technology (Theranostics & CDx) industry across global and Chinese markets.
2.Estimation of the overall market size of the Pharmacogenomics Technology (Theranostics & CDx) industry, along with a detailed analysis of market share by major countries.
3.Evaluation of the development potential within various segments of the Pharmacogenomics Technology (Theranostics & CDx) industry, analysis of downstream market demand, and an examination of the competitive landscape.
4.Identification and exploration of industry pain points, aiming to support stakeholders in addressing key challenges effectively.
This report integrates extensive desk research with qualitative interviews conducted with industry experts and insiders, ensuring both the objectivity and comprehensiveness of the findings and data.
The study provides a detailed examination of the production, consumption, import, and export dynamics of the Pharmacogenomics Technology (Theranostics & CDx) market in China. It also highlights key global and domestic manufacturers that play a significant role in the Chinese market, presenting core performance indicators such as sales volume, revenue, pricing, gross margin, and market share.
Furthermore, the report delivers a thorough analysis of segmented growth within the Pharmacogenomics Technology (Theranostics & CDx) product category, including differentiation by product types, pricing, sales, revenue, and application-specific market performance. Historical data from 2020 to 2024 is incorporated, with forward-looking projections extending through 2031.
In light of the significant uncertainty introduced by the U.S. tariff policy set to take effect in 2025, the report offers a dedicated analysis of its core impacts. This includes assessments of global and regional competitive dynamics, economic linkages, supply chain restructuring, and countries’ strategic responses. The report concludes with strategic recommendations and a forward-looking outlook for the Pharmacogenomics Technology (Theranostics & CDx) market.
1. Key Global Players in the Pharmacogenomics Technology (Theranostics & CDx) Industry:
Illumina
F. Hoffmann-La Roche
Agilent
Abbott
Thermo Fisher Scientific
Qiagen
Guardant Health
MGI Tech
Amoy Diagnostics
BGI Group
2.Global Pharmacogenomics Technology (Theranostics & CDx) Market, Segmented by Product Type:
Instruments
Reagents and Consumables
Other
3. Global Pharmacogenomics Technology (Theranostics & CDx) Market, Segmented by Application
Tumour
Diabetes
Mental Illness
Cardiovascular Disease
Other
4. Global Pharmacogenomics Technology (Theranostics & CDx) Market, by Geographical Region:
North America (USA and Canada)
Europe (Germany, UK, France, Italy and other European countries)
Asia-Pacific (China, Japan, Korea, Taiwan, Southeast Asia, India, etc.)
Latin America (Mexico and Brazil, etc.)
Middle East and Africa (Turkey and Saudi Arabia, etc.)
I. Pharmacogenomics Technology (Theranostics & CDx) Market Overview:
1.1 Product Definition and Statistical Scope
1.2 On the basis of different product types, Pharmacogenomics Technology (Theranostics & CDx) can be mainly categorized as follows:
Global Growth Trend of Pharmacogenomics Technology (Theranostics & CDx) by Product Type 2020 VS 2024 VS 2031
Instruments
Reagents and Consumables
Other
1.3 From different applications, Pharmacogenomics Technology (Theranostics & CDx) mainly includes the following:
Global Different Applications Pharmacogenomics Technology (Theranostics & CDx) Growth Trend 2020 VS 2024 VS 2031
Tumour
Diabetes
Mental Illness
Cardiovascular Disease
Other
1.4 Global Pharmacogenomics Technology (Theranostics & CDx) Development Status and Future Trends (2020-2031)
Global Market Pharmacogenomics Technology (Theranostics & CDx) Revenue and Growth Rate (2020-2031)
Global Market Pharmacogenomics Technology (Theranostics & CDx) Sales and Growth Rate (2020-2031)
II. Global Market Major Pharmacogenomics Technology (Theranostics & CDx) Manufacturers Analysis:
2.1 Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales and Market Share
Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales (2020-2025)
Global Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales Market Share (2020-2025)
2.2 Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Revenue and Market Share
Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Revenue (2020-2025)
Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share (2020-2025)
Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Revenue Ranking by 2024
2.3 Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Price (2020-2025)
2.4 Global Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Headquarter and Origin Distribution
2.5 Global Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Establishment Date and Pharmacogenomics Technology (Theranostics & CDx) Commercialization Date
2.6 Global Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Product Type and Application
2.7 Pharmacogenomics Technology (Theranostics & CDx) Industry Concentration, Competition Analysis
Pharmacogenomics Technology (Theranostics & CDx) Industry Concentration Analysis: Global Top 5 Manufacturers Market Share by 2024
Global Market Pharmacogenomics Technology (Theranostics & CDx) First Tier, Second Tier and Third Tier Manufacturers (Brand) and Market Share in 2024.
2.8 New Investments and Market M&A Activities
III. Profiles of the following key players:
Illumina
F. Hoffmann-La Roche
Agilent
Abbott
Thermo Fisher Scientific
Qiagen
Guardant Health
MGI Tech
Amoy Diagnostics
BGI Group
1. Basic Information, Pharmacogenomics Technology (Theranostics & CDx) Manufacturing Base, Headquarters, Competitors and Market Position.
2. Pharmacogenomics Technology (Theranostics & CDx) Product Specifications, Parameters, and Market Applications .
3. Pharmacogenomics Technology (Theranostics & CDx) Sales, Revenue, Price and Gross Margin in Global Market (2020-2025).
4. Company Profile and Key Businesses.
5. Latest Company News.
IV. Analysis of Different Product Types of Pharmacogenomics Technology (Theranostics & CDx):
4.1 Global Market Pharmacogenomics Technology (Theranostics & CDx) Sales by Product Type (2020-2031)
Global Market Sales and Market Share of Pharmacogenomics Technology (Theranostics & CDx) by Product Type (2020-2025)
Global Market Sales Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Different Product Types (2026-2031)
4.2 Global Market Pharmacogenomics Technology (Theranostics & CDx) Size by Product Type (2020-2031)
Global Market Pharmacogenomics Technology (Theranostics & CDx) Size and Market Share by Product Type (2020-2025)
Global Market Size Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Product Type (2026-2031)
4.3 Global Market Price Trend of Pharmacogenomics Technology (Theranostics & CDx) by Product Type (2020-2031)
V. Analysis of Pharmacogenomics Technology (Theranostics & CDx) for Different Applications
5.1 Global Market Sales of Pharmacogenomics Technology (Theranostics & CDx) by Application (2020-2031)
Global Market Pharmacogenomics Technology (Theranostics & CDx) Sales and Market Share by Application (2020-2025)
Global Market Pharmacogenomics Technology (Theranostics & CDx) Sales Forecast by Application (2026-2031)
5.2 Global Market Pharmacogenomics Technology (Theranostics & CDx) Size and Market Share by Application (2020-2025)
Global Market Pharmacogenomics Technology (Theranostics & CDx) Size Forecast by Application (2026-2031)
5.3 Global Market Price Trend of Pharmacogenomics Technology (Theranostics & CDx) by Application (2020-2031)
VI. Industry Development Environment Analysis
6.1 Development Analysis of Pharmacogenomics Technology (Theranostics & CDx) Industry - Development Trend
6.2 Pharmacogenomics Technology (Theranostics & CDx) Industry Development Analysis - Manufacturer Barriers
6.3 Pharmacogenomics Technology (Theranostics & CDx) Industry Development Analysis - Driving Factors
6.4 Pharmacogenomics Technology (Theranostics & CDx) Industry Development Analysis - Restraints
6.5 SWOT Analysis of Pharmacogenomics Technology (Theranostics & CDx) Global Companies
6.6 Pharmacogenomics Technology (Theranostics & CDx) Industry Development Analysis - Industry Policies
Industry Authorities and Regulatory Framework
Industry-related Policy Trends
Industry Related Planning
VII. Industry Supply Chain Analysis
7.1 Industry Chain Introduction of Pharmacogenomics Technology (Theranostics & CDx) Industry
7.2 Pharmacogenomics Technology (Theranostics & CDx) Industry Chain Analysis - Upstream
7.3 Pharmacogenomics Technology (Theranostics & CDx) Industry Chain Analysis - Midstream
7.4 Pharmacogenomics Technology (Theranostics & CDx) Industry Chain Analysis - Downstream
7.5 Procurement Mode of Pharmacogenomics Technology (Theranostics & CDx) Industry
7.6 Production Mode of Pharmacogenomics Technology (Theranostics & CDx) Industry
7.7 Pharmacogenomics Technology (Theranostics & CDx) Industry Sales Model and Sales Channels
VIII. Global Local Pharmacogenomics Technology (Theranostics & CDx) Capacity, Production Analysis
8.1 Global Pharmacogenomics Technology (Theranostics & CDx) Supply and Demand Status and Forecast (2020-2031)
Global Pharmacogenomics Technology (Theranostics & CDx) Capacity, Production, Capacity Utilization and Development Trend (2020-2031)
Global Pharmacogenomics Technology (Theranostics & CDx) Production, Market Demand and Development Trend (2020-2031)
8.2 Global Pharmacogenomics Technology (Theranostics & CDx) Import and Export Analysis
Global Market Pharmacogenomics Technology (Theranostics & CDx) Main Import Sources
Global Market Pharmacogenomics Technology (Theranostics & CDx) Main Export Destinations
IX. Research Findings and Conclusion
X. Appendix
10.1 Research Methodology
10.2 Data Sources
Secondary Information Sources
Primary Information Sources
10.3 Data Interactive Validation
10.4 Disclaimer”
Table of Contents
Table : Growth Trends in Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table:Growth Trend of Different Applications
Table:Current Development Status of Pharmacogenomics Technology (Theranostics & CDx) Industry
Table:Development Trend of Pharmacogenomics Technology (Theranostics & CDx)
Table:Global Major Regions Production of Pharmacogenomics Technology (Theranostics & CDx)
Table:Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Production Market Share
Table:Global Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Production Capacity
Table:Global Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales, Sales Market Share, Sales Revenue
Table:Global Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales Revenue Market Share, Price
Table: Global Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Revenue Ranking by 2025
Table: China Market Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales, Sales Market Share, Sales Revenue
Table: China Market Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Sales Revenue Market Share, Sales Price
Table: China Key Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Revenue Ranking by 2025
Table: Global Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Production Distribution and Commercialization Date
Table:Global Major Manufacturers Pharmacogenomics Technology (Theranostics & CDx) Product Type List
Table: Global Key Manufacturers Market Position of Pharmacogenomics Technology (Theranostics & CDx) in 2025 (First Tier, Second Tier and Third Tier)
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Market Analysis of Current Status of Investments, Mergers & Acquisitions, and Others
Table: Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Sales Revenue
Table: Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Sales Revenue Market Share
Table: Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share
Table: Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Sales Volume
Table: Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Sales Market Share
Table : Global Major Regions Pharmacogenomics Technology (Theranostics & CDx) Sales Share
Table : The following companies:
Illumina
F. Hoffmann-La Roche
Agilent
Abbott
Thermo Fisher Scientific
Qiagen
Guardant Health
MGI Tech
Amoy Diagnostics
BGI Group
Pharmacogenomics Technology (Theranostics & CDx) Manufacturing Base, Sales Area, Competitors and Market Position
Pharmacogenomics Technology (Theranostics & CDx) Product Specifications, Parameters and Market Applications
Pharmacogenomics Technology (Theranostics & CDx) Sales, Revenue, Price and Gross Margin
Company Profile and Major Businesses
Latest Company News
Table: Global Sales of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Sales Market Share of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Sales Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Sales Market Share Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Revenue of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Product Type
Table: Global Revenue Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Revenue Market Share Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Price Trend of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Table: Global Sales of Pharmacogenomics Technology (Theranostics & CDx) by Application
Table: Global Sales Market Share of Pharmacogenomics Technology (Theranostics & CDx) by Application
Table: Global Sales Forecast of Pharmacogenomics Technology (Theranostics & CDx) by Application
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Sales Market Share Forecast by Application
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Application
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Application
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Forecast by Application
Table: Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share Forecast by Application
Table: Global Price Trend of Pharmacogenomics Technology (Theranostics & CDx) by Application
Table: List of Pharmacogenomics Technology (Theranostics & CDx) Upstream Raw Material Suppliers and Contact Information
Table: List of Typical Customers of Pharmacogenomics Technology (Theranostics & CDx)
Table: Pharmacogenomics Technology (Theranostics & CDx) Main Sales Modes and Sales Channels
Table: Development Opportunities and Key Driving Factors of Pharmacogenomics Technology (Theranostics & CDx) Industry
Table: Risks Faced by Pharmacogenomics Technology (Theranostics & CDx) Industry Development
Table: Pharmacogenomics Technology (Theranostics & CDx) Industry Policy Analysis
Table: Research Scope
Table: List of Analysts
Chart Catalog
Figure Pharmacogenomics Technology (Theranostics & CDx) Product Picture
Figure Global Production Market Share of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Consumption Market Share by Application
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Capacity, Production, Capacity Utilization and Development Trend
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Production, Demand and Development Trend
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Production Market Share by Major Regions
Figure China Pharmacogenomics Technology (Theranostics & CDx) Capacity, Production, Capacity Utilization and Development Trend
Figure China Pharmacogenomics Technology (Theranostics & CDx) Production, Market Demand and Development Trend
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Market Sales and Growth Rate.
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Market Size
Figure Global Market Pharmacogenomics Technology (Theranostics & CDx) Sales and Growth Rate
Figure Global Market Pharmacogenomics Technology (Theranostics & CDx) Price Trend
Figure Global Market Pharmacogenomics Technology (Theranostics & CDx) Sales Market Share of Major Manufacturers in 2025
Figure Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share of Key Manufacturers in Global Market in 2025
Figure Pharmacogenomics Technology (Theranostics & CDx) Sales Market Share of Key Manufacturers in China Market in 2025
Figure Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share of Key Manufacturers in China Market, 2025
Figure 2025 Global Pharmacogenomics Technology (Theranostics & CDx) Market Share of Top 5 Manufacturers
Figure 2025 Global Pharmacogenomics Technology (Theranostics & CDx) First Tier, Second Tier and Third Tier Manufacturers (by Brand) and Market Share
Figure Global Pharmacogenomics Technology (Theranostics & CDx) Sales Revenue Market Share by Major Regions
Figure North America Pharmacogenomics Technology (Theranostics & CDx) Sales and Growth Rate
Figure North America Pharmacogenomics Technology (Theranostics & CDx) Revenue and Growth Rate
Figure Europe Market Pharmacogenomics Technology (Theranostics & CDx) Sales and Growth Rate
Figure Europe Market Pharmacogenomics Technology (Theranostics & CDx) Revenue and Growth Rate
Figure China Pharmacogenomics Technology (Theranostics & CDx) Sales and Growth Rate
Figure China Market Pharmacogenomics Technology (Theranostics & CDx) Revenue and Growth Rate
Figure Pharmacogenomics Technology (Theranostics & CDx) Sales and Growth Rate in Japan Market
Figure Pharmacogenomics Technology (Theranostics & CDx) Revenue and Growth Rate in Japan Market
Figure Global Price Trend of Pharmacogenomics Technology (Theranostics & CDx) by Product Type
Figure Global Price Trend of Pharmacogenomics Technology (Theranostics & CDx) by Application
Figure Pharmacogenomics Technology (Theranostics & CDx) Industry Chain
Figure Pharmacogenomics Technology (Theranostics & CDx) Chinese Companies SWOT Analysis
Figure Key Interview Objectives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
2025-04-19 12:38:40 
Pages: 106 
Tables: 134 
